386 related articles for article (PubMed ID: 2146285)
1. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
Falcone T; Finegood DT; Fantus IG; Morris D
J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
[TBL] [Abstract][Full Text] [Related]
2. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
Buyalos RP; Geffner ME; Azziz R; Judd HL
Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
[TBL] [Abstract][Full Text] [Related]
3. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
[TBL] [Abstract][Full Text] [Related]
4. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose effectiveness in patients with polycystic ovary syndrome.
Falcone T; Little AB; Morris D
Hum Reprod; 1992 Aug; 7(7):922-5. PubMed ID: 1430129
[TBL] [Abstract][Full Text] [Related]
6. The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.
Carbunaru G; Prasad P; Scoccia B; Shea P; Hopwood N; Ziai F; Chang YT; Myers SE; Mason JI; Pang S
J Clin Endocrinol Metab; 2004 Feb; 89(2):783-94. PubMed ID: 14764797
[TBL] [Abstract][Full Text] [Related]
7. The relationship between insulin sensitivity and insulin-like growth factor-binding protein-1.
Morris DV; Falcone T
Gynecol Endocrinol; 1996 Dec; 10(6):407-12. PubMed ID: 9032568
[TBL] [Abstract][Full Text] [Related]
8. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
[TBL] [Abstract][Full Text] [Related]
9. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
10. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
11. Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women.
Azziz R; Bradley EL; Potter HD; Parker CR; Boots LR
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1251-6. PubMed ID: 7726265
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
Ehrmann DA; Cavaghan MK; Imperial J; Sturis J; Rosenfield RL; Polonsky KS
J Clin Endocrinol Metab; 1997 Feb; 82(2):524-30. PubMed ID: 9024248
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?
Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM
Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052
[TBL] [Abstract][Full Text] [Related]
14. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS; Finegood D; Dunaif A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
[TBL] [Abstract][Full Text] [Related]
15. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
[TBL] [Abstract][Full Text] [Related]
16. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women.
Smith S; Ravnikar VA; Barbieri RL
Fertil Steril; 1987 Jul; 48(1):72-7. PubMed ID: 3297813
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.
Asagami T; Holmes TH; Reaven G
Metabolism; 2008 Oct; 57(10):1355-60. PubMed ID: 18803938
[TBL] [Abstract][Full Text] [Related]
18. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
Rittmaster RS; Deshwal N; Lehman L
J Clin Endocrinol Metab; 1993 May; 76(5):1295-300. PubMed ID: 8388405
[TBL] [Abstract][Full Text] [Related]
19. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.
Dunaif A; Finegood DT
J Clin Endocrinol Metab; 1996 Mar; 81(3):942-7. PubMed ID: 8772555
[TBL] [Abstract][Full Text] [Related]
20. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
